Category: CannabisNewsWire Release

CannabisNewsBreaks — AROYA Releases OpenSprinkler Integration, Empowers Cannabis Growers to ‘Not Only Survive, But Also Thrive’

AROYA, a division of ADDIUM Inc., announced a wide release of its integration with the controller OpenSprinkler; the integration empowers growers by providing data to guide their crop-steering decisions while also simplifying an additional aspect of cannabis cultivation. According to the announcement, the release brings added visibility and data-driven control to commercial cultivation and cultivators’ irrigation strategies; the announcement also noted that an estimated 30-40% of cultivators currently use OpenSprinkler for drip irrigation. The new integration eliminates the need to access other programs separate spreadsheets, reducing complexity while bringing more visibility to commercial cultivation. “Enabling integrations with third-party systems solidifies AROYA’s unrivaled position as the cannabis industry’s most intuitive platform, providing growers with the control, flexibility, visibility, and data-driven insights to manage every stage of cultivation,” said AROYA president Scott Campbell in the press release. “It made sense for us to take just one more small step, not to become a controls company but to offer an integration with a controlled system that people commonly use in the cannabis industry. Now cultivators can have much better control and take those insights that they get from looking at their data and put it right to what changes they’re going to make, which is their irrigation strategy, without having to leave the platform. . . . Simply put, we empower growers of all sizes with intelligent automation to not only survive, but also thrive in increasingly competitive markets.”

To view the full press release, visit https://cnw.fm/dxjrb

About AROYA 

AROYA is the leading cannabis production platform, combining forward-thinking science, sensors and software to empower cultivators with data-driven insights that help them increase yield, scale operations and achieve consistent quality. Based in Washington, AROYA brings 30 years of experience in sensor development to the ag tech industry, enabling cultivators to do more with less while making more purpose-driven decisions for their businesses. For more information about the company, visit www.AROYA.io.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Missouri Sees Uptick in Marijuana Jobs Shortly After Legalization Ballot

Despite its relative youth, America’s nascent cannabis industry has been one of the most prolific job creators in the country. As of January 2022, more than 420,000 people nationwide had full-time jobs in the state-legal cannabis industry. The industry has been among the fastest-growing sectors in the country in recent years, and it is predicted to be worth $47.5 billion by 2030 as more states launch their own markets and sales pick up.

Missouri, a traditionally conservative state, is enjoying some of the labor benefits of cannabis reform after it recently approved recreational cannabis sales. Only a few months after Missouri voters approved an adult-use cannabis measure at the November ballot, thousands of residents are already earning a living from the marijuana industry.

State officials began approving retail cannabis licenses for dispensaries in early January, and the first businesses met significant product demand from customers. Less than a month after the first licenses were approved, close to 200 dispensaries had sold around $103 million worth of cannabis products, with the majority (about $72 million) coming from recreational cannabis.

Individuals who want to work in Missouri’s cannabis industry have to secure agent ID badges from the state. The state Department of Health and Human Sciences says it approved 12,970 agent ID badges by the end of February. With the market in its infancy, experts predict that the job growth within Missouri’s cannabis industry will only go up.

Se7en Staffing & Employment Solutions CEO Christy Essex says that her company has noted an increase in labor needs across the industry that still hasn’t been met. Dispensaries are having trouble keeping their shelves filled, she said, and some companies are hiring temporary employees to cover short-term labor shortfalls.

Sloane Barbour, the CEO of cannabis technology company engin, says that Missouri’s impressive performance in its first month has made it a standout in America’s state-legal cannabis space. Cannabis is posed to become a multibillion dollar industry, and she believes Missouri has the potential to compete with juggernauts such as Massachusetts and Illinois. She noted that states with billion-dollar markets, including Illinois, Massachusetts and Michigan, often employ around 30,000 to 50,000 employees in the marijuana industries.

As such, Barbour said, Missouri’s cannabis market still has plenty of potential for job growth, especially in the short-term as businesses begin hiring aggressively. This hiring spree may be slowed down if lawmakers advance a bill that would include fingerprinting as part of the background checks required before receiving an agent ID badge.

No such extensive procedures may be required if marijuana products intended for medical use were approved by the FDA in the way that companies such as IGC Pharma Inc. (NYSE American: IGC) hope for. These companies are working to see chronic pain formulations from cannabis be approved as mainstream medicines.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Colombian Authorities Seize More Than 8,000 Pounds of Marijuana in Maritime Operations

More than 8,000 pounds of cannabis were confiscated last week in several maritime operations that resulted in two ships sinking. Three ships in total were intercepted, while one sunk while attempting to evade Navy ships, according to a statement released by the Columbian Navy on Saturday. The Navy released a video on Twitter showing officers unloading marijuana packages, which were estimated to be worth $29 million.

The first incident took place when a Navy aircraft discovered a ship that was traveling in the northern Pacific region at a “high velocity.” The vessel eventually sank as a result of the water absorption brought on by the bad weather. Two people on board were rescued by authorities, who also seized cannabis packages totaling almost 5,000 pounds.

In another raid, authorities claimed that a fast ship had been spotted in the middle of the Pacific. Officials who intercepted the boat reported that more than 1,000 cannabis packages totaling 2,000 pounds were seized, and two people on it were arrested.

In the third incident, units from the Pacific Maritime Naval Force discovered a vessel with three people on board about 50 miles from the Baha Solano Coastline. Officials said the boat attempted to escape using evasive maneuvers but was unsuccessful and eventually sank. Those on board were rescued from drowning by the officers. Later, the Navy reported that 46 packages that had drifted to sea and contained around 2,000 pounds of cannabis were recovered.

Officials reported that a total of seven people were arrested and that more than 700,000 doses of cannabis were seized from the three incidents. The suspects will be charged with a number of felonies, including producing, trafficking, and carrying illegal drugs.

The Navy of Colombia has been active in capturing drug-laden ships off the country’s coast. A semi-submarine ship carrying almost 1,000 cocaine packages was stopped last month. Three men who were on board were arrested during the seizure. About a week prior, authorities in the same area busted another submarine carrying an enormous amount of drugs, two dead bodies, and two survivors. The 50-foot sub was carrying nearly 5,800 pounds of cocaine, which is worth more than $87 million. According to the Navy, the ship was headed for Central American nations, and the seizure prevented the sale of more than 6 million cocaine doses on the black market.

If marijuana were legal in Columbia, there would probably be fewer cannabis seizures since citizens would have access to a legal supply of the substance, and there would be additional benefits arising from the mushrooming of ancillary companies such as Advanced Container Technologies Inc. (OTC: ACTX) serving players in the U.S. marijuana space.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Lift Toronto 2023 Cannabis Conference and Expo Announces Speakers and Sessions; Registration Now Open

Thousands of cannabis industry and community members will gather at the Metro Toronto Convention Centre, June 1-3, for three high-energy days of discovery, education, entertainment and more. 

The highly anticipated Lift Toronto 2023 Cannabis Conference and Expo, which will bring together thousands of cannabis industry professionals and consumers from all parts of the cannabis ecosystem, returns to the Metro Toronto Convention Centre from June 1-3, 2023. Hundreds of exhibiting companies will showcase the latest in cannabis products, services and innovations; industry leaders and fresh voices will take the stage; and new experiences and activations will lead to Lift’s signature a-ha moments. Registration is now open, with special “early bird” pricing available for a limited time.

The three-day event kicks off on Thursday June 1 with the Lift Cannabis Business Conference (“LCBC”), an all- business strategy forum focusing on the drivers of forward momentum, overcoming systemic challenges, and advancing innovative business and regulatory solutions that will generate meaningful change and sustainable growth in Canada’s cannabis industry. 

Session highlights from LCBC include: 

  • Keynotes & Spotlight Presenters: Priorities & Progress of Canada’s Cannabis Industry, Fairness in Banking, and What the CannTrust Case Taught Us
  • Canada’s Brands & World View Leadership Panels: Bullish and Bearish, New and Established, International Markets and How to Remain Competitive and Grow
  • Legacy Consumers to Legal: What the Illicit Market Can Teach the Legal Market
  • Plus: Winning Confidence of Lenders & Investors; The Growth of Extracts, Concentrates & Processing; and (Caged) Guerrilla Cannabis Marketing.

With An Outstanding Roster of Speakers: Anna-Sophia Kouparanis, Co-Founder, Bloomwell Group (Germany) | Guillermo Delmonte, Founder, NDLATAN (Uruguay) | Niel Marotta, CEO & Founder, INDIVA | Brishna Kamal, President, Whistler Therapeutics | John Fowler, CEO, Muskoka Grown | David Goldstein, CEO, Stoke Inventory Partners | Mike Schilling, CEO, Community Savings Credit Union | Katy Perry, CEO, TOKE Cannabis | Adam Temple, CEO, Evolved Extraction Solutions | Andrew Fischer, CEO, Protonify | Dave Marino, President, Spirit Leaf Ontario & Superette Ontario 

“We are really pushing the envelope for our next trip to Toronto with top-tier presenters on red hot topics,” says Barry Smith, Canadian Content Director, Lift Events & Experiences. “Each session has been carefully curated to energize, inspire, educate and motivate all of our audiences from across the entire cannabis community.” 

On Friday, June 2, Industry & Budtender Day will feature multiple stages with individually-crafted content to inform and spark conversations that will drive the industry forward in the coming year. Saturday, June 3, is Consumer Day, open again to industry members and budtenders, as well as everyone from the canna-curious to the canna-connoisseur. 

Session highlights from the Expo floor include: 

  • Budtender Masterclass: Product knowledge, retail operations and new harm reduction toolkit. 
  • Maestros of Marketing: Power panel featuring key brand and retail players. 
  • Unforgettable Edibles & Beverages: New tastes for fun and relaxation. 
  • Diversity Dividend: The bottom-line benefits and just good policy. 
  • Cannabis Tourism Spotlight: Everything about leisure, lounges and adventures. 
  • Craft Cannabis: Hitting new highs, one small batch at a time. 
  • & so much more!

In addition, on both Friday and Saturday, the Lift expo floor will showcase a wide array of leading and emerging exhibitors while debuting fresh experiences, education and activations including: 

  • The Diner’s Club: Don’t miss the hottest culinary cannabis trends and insights. 
  • Morning Mic-Drop: A laugh out loud comedy performance from The Noobie and The Doobie, Timmy Boyle & Marijane Baker. 
  • PLAY@Lift: Enjoy games, photo opps, sweets and more. 
  • Outdoor Networking Lounge: The place to be for a catch-up sesh. 
  • Brand Discovery Zone: See what’s new with your favorite and emerging brands. 
  • Budtender Lounge: A dedicated area to mix and mingle with your colleagues. 
  • Lift After Party: Enjoy live music, drinks, bites and networking to end the show on a high note. 

Event Schedule 

Lift Cannabis Business Conference | Thursday, June 1, 2023 | 9 a.m. – 5 p.m.

Lift Expo Industry Days | Friday, June 2 and Saturday, June 3, 2023 | 11 a.m. – 5 p.m. 

Lift Expo Consumer Day | Saturday, June 3, 2023 | 11 a.m. – 5 p.m. 

Click to view ticket types and pricing 

Up Next:
Lift San Francisco: August 2-4, 2023 | Moscone Convention Center
San Francisco speaker applications are open, and exhibits and partnerships are now available. Registration for Lift San Francisco will open later this spring. 

For more information or to schedule an interview, contact Sacha Cohen at 202-251-9417 or sacha@themaverickpr.com

About Lift

Lift Events & Experiences serve the cannabis community as both a meeting place and a destination for discovery. With dates across North America, each Lift event showcases leading-edge content and premiere exhibitors in a high-energy setting for thousands of cannabis growers, processors, manufacturers, brands, budtenders, retailers, educators, advocates, regulators, consumers, investors and more – while paying tribute to the roots of this rapidly-evolving industry. Lift is proudly produced by MCI. For more information, visit LiftEvents.com.

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Bipartisan Bill Before Congress Seeks to Force DEA to Allow Patient Use of Cannabis, Psychedelics

A bipartisan group of congressional lawmakers has filed a measure that would compel the U.S. Drug Enforcement Administration (DEA) to allow seriously ill patients to use psychedelics and cannabis. The bill would clarify that gravely ill individuals have the right to access alternative treatments under federal Right to Try (RTT) laws that allow them to use schedule 1 drugs if they don’t get any relief from traditional treatments.

An RTT policy signed into law by President Donald Trump when he was still in office already grants terminally ill patients access to investigational drugs that have gone through clinical trials, even if they are classified in schedule 1 of the Controlled Substances Act. However, the DEA refused to allow a Seattle physician to offer psilocybin therapy under RTT laws to patients with terminal conditions in 2021, forcing the doctor to file a series of lawsuits against the agency to compel it to grant psychedelic access to end-of-life patients.

The recent bill would amend existing law to clarify that despite the DEA’s move to reject psilocybin access under RTT laws, end-of-life patients should be able to use such treatments. The Right to Try Clarification Act was introduced by Representatives Nancy Mare and Earl Blumenauer and cosponsored by Representatives Andy Biggs, Lou Correa and Madeline Dean.

Led by Senators Rand Paul and Cory Booker and Representatives Early Blumenauer and Nancy Mae, a prior version of the bill was introduced in Congress last year, but it failed to advance.

Blumenauer said that patients with terminal illnesses have the right to discuss treatments such as psilocybin that could provide long-term relief from symptoms such as anxiety, depression and pain. He noted that such patients had been prevented from accessing beneficial treatments due to federal restrictions for too long and that the proposed bill would finally allow these individuals to try alternative treatments that could provide sustained relief regardless of the classification of the treatments on the Controlled Substances Act.

Forty-one states have Right to Try laws that allow terminally ill patients to access treatments in investigational stages, including psilocybin, Blumenauer said. He added that MDMA and psilocybin have exhibited much medical potential in early clinical trials. Despite this, Blumeauer continued, the DEA has “refused to accommodate” RTT laws and denied end-of-life patients the right to choose their preferred treatments.

If his bill succeeds, it could impact the ongoing case that has seen the DEA field lawsuits from a physician and patients trying to access psilocybin therapy.

Meanwhile, a number of companies, including IGC Pharma Inc. (NYSE American: IGC), are investing millions of dollars into developing therapeutic formulations from cannabis. These formulations could get approved by the FDA if the development process proceeds as the startups hope they will.

NOTE TO INVESTORS: The latest news and updates relating to IGC Pharma Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Montana Senators Reject Bill Seeking to Impose THC Limits, Ban Adult-Use Shops

Last Thursday, Montana’s Senate Committee for Economic and Labor Affairs approved SB 546 on a 6-to-4 vote count, giving it a pass for further Senate discussion. The bill, introduced by Senator Keith Regier, aimed to significantly reduce the potency of the medicinal cannabis plant and products in Montana by outlawing adult-use marijuana businesses, increasing the taxation on medical cannabis from 4% to 20%, and placing strict restrictions on the amount that can be legally possessed. It also aimed to reduce the number of marijuana plants grown for personal use from two to one.

Advocates for medicinal marijuana challenged the law, claiming it would prevent patients who depend on it for treating pain and other conditions from accessing it. Numerous individuals would not have been able to afford medical marijuana because of the anticipated tax rise.

Three GOP committee members — Committee Chair Jason Small, Senate President Jason Ellsworth and Senator Sales Walt — joined forces with all three Democratic members to reject the measure. Supporters of medical cannabis who have pushed for access to relatively affordable medical marijuana celebrated this ruling as a victory.

The strength of cannabis and youthful access were issues brought up by the bill’s supporters at the committee session on Thursday and the debate on Wednesday. Bill 546 would have reduced the permissible concentration of the psychoactive component THC in medicinal cannabis flowers from 35% to 10% and outlawed concentrates with higher THC concentrations.

The bill’s opponents said that it would have resulted in the loss of dozens of industrial jobs, encouraged the growth of a black market and prevented the state from collecting a significant amount of taxes. Although Small admitted that he favors some aspects of the proposal, he claimed that the bill is difficult to pass at this point of the session.

Currently, Montana regulation does not place a limit on the potency of cannabis extract products. The committee’s move to table the draft SB 546, which sought to regulate the strength of medical cannabis flower and extracts in Montana, suggests that additional discussion is required prior to passing any new laws.

It’s crucial to strike a balance between the demands of patients who require medical cannabis and worries about strength and young individuals’ access, as well as the effects on industry employment and tax income. The proposed measure might later be amended or reintroduced.

The failure of this measure leaves patients with marijuana cards still able to grow their own medicinal cannabis plants using some modern equipment, such as the mini-gardens sold by Advanced Container Technologies Inc. (OTC: ACTX).

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

CannabisNewsBreaks – IBN, CannabisNewsWire to Drive Reach of Lift Toronto 2023

IBN (“InvestorBrandNetwork”), an innovative content distributor and multifaceted communications organization with 50+ brands including CannabisNewsWire, today announced its latest event collaboration with the organizers of Lift Toronto, which will return to the iconic Metro Toronto Convention Centre in Toronto, Ontario, on June 1-3, 2023. Lift Toronto is projected to showcase 150-plus exhibiting companies, 140-plus speakers and featured panelists and draw up to 5,000 attendees to the event, which is open to all audiences across the full cannabis industry and community. IBN and CannabisNewsWire will leverage their array of extensive corporate communications solutions to drive recognition for Lift Toronto 2023 participants seeking to enhance visibility among investors, journalists, consumers and the broader public. “Lift is a highly professional organization with a long track record of successful cannabis events. We are very pleased to continue our collaboration as an official media sponsor and work with their wonderful team,” said Cami Cox, director of analytics and reporting for CannabisNewsWire. “Lift Toronto is the premier cannabis event in Canada and offers world-class educational opportunities for anyone in the space. Moreover, the diverse exhibitor list and high-powered networking make this event a favorite.”

To view the full press release, visit https://cnw.fm/pJ32d

About IBN

IBN (InvestorBrandNetwork) consists of financial brands introduced to the investment public over the course of 17+ years. With IBN, we have amassed a collective audience of millions of social media followers. These distinctive investor brands aim to fulfill the unique needs of a growing base of client-partners. IBN will continue to expand our branded network of highly influential properties, leveraging the knowledge and energy of specialized teams of experts to serve our increasingly diversified list of clients.

Through NetworkNewsWire (“NNW”) and its affiliate brands, IBN provides: (1) access to a network of wire solutions via InvestorWire (“IW”) to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) full-scale distribution to a growing social media audience; (5) a full array of corporate communications solutions; and (6) a total news coverage solution.

For more information, please visit https://www.InvestorBrandNetwork.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://IBN.fm/Disclaimer

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive SMS text alerts from CannabisNewsWire, text “Cannabis” to 844-397-5787 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.

420 with CNW — Germany to Proceed with Toned-Down Marijuana Legalization Plan as EU Review Awaits

Officials in Germany intend to move forward with a toned-down version of cannabis legalization after abandoning — at least temporarily — a more comprehensive proposal that would have brought about legal cannabis sales throughout the nation. Karl Lauterbach, the nation’s health minister, had promised to introduce new marijuana regulations by the end of March this year.

The new model, which consists of two parts, was first reported by Zeit and aims to legalize cannabis countrywide without breaking EU regulations. The model will, for four years, permit restricted cannabis sales in some areas, much like a pilot program. In doing so, officials would be able to observe how reforms were being implemented in both urban centers and more rural areas. The program can then be expanded to other regions of the nation if it is deemed successful.

Lauterbach’s plan would also permit Germans to cultivate marijuana for personal use. While the latter part of the plan would require review by the EU Commission, the former would not, according to reports.

Although specifics of the homegrow rules have not been decided, reports indicate that the proposal would permit consumers to own up to 30 marijuana plants. Additionally, independent cultivators can distribute the produce among themselves via “marijuana clubs.” These clubs are already legal in Spain and the Netherlands.

Last year, government representatives from the Netherlands, Germany, Luxembourg and Malta met to talk about legalizing marijuana. Moreover, the country’s federal cabinet approved a preliminary outline for a legalization bill at the end of last year, but the government wanted European Union approval to make sure that enacting the legislation wouldn’t violate international obligations.

Under that preliminary framework, persons older than 18 years of age would have legal access to possess up to 30 grams of cannabis, which could be bought from establishments with federal licenses. Eligible persons could also cultivate up to three marijuana plants for their own use, subject to restrictions on enclosure to keep minors out.

The plan calls for a special consumption tax in addition to the nation’s sales tax being applied to marijuana. And after the reform is put into effect, all ongoing criminal cases involving offenses that are now legal will be halted.

Earlier this month, Lauterbach stated that officials would be revising the proposal before introducing a bill in parliament as they had received “positive feedback” from the EU The framework was the result of several months of analysis and discussion between the German government and the nation’s coalition government. A series of hearings intended to inform legislation to end the nation’s prohibition were launched last summer by officials as a steppingstone toward legalization.

As more countries around the world take steps to end the prohibition of marijuana, many companies such as India Globalization Capital Inc. (NYSE American: IGC) are going a step further to develop medicines from compounds extracted from this plant, and these compounds are expected to gain the approval of regulators once the the clinical development process has been successfully completed.

NOTE TO INVESTORS: The latest news and updates relating to India Globalization Capital Inc. (NYSE American: IGC) are available in the company’s newsroom at https://cnw.fm/IGC

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

420 with CNW — Illinois Senate Approves Bill Blocking Police from Using Cannabis Smell as Probable Cause for Searches

Illinois Senators have voted in favor of a measure that would prevent law enforcement from using cannabis smell as a probable cause for vehicle searches. Senator Rachel Ventura sponsored the measure, which advanced in a 33-to-20 vote and is now headed to the Illinois House of Representatives for consideration.

Ventura said that her legislation was meant to protect Illinoisians from unreasonable searches at traffic stops. She noted that law enforcement tends to pull over people of color “far too often” and that the odor of cannabis shouldn’t be probable cause for these stops. Recreational cannabis is legal for both residents and nonresidents in the state, and the plant’s “pungent scent” sticks to clothing for long after initial consumption, she said.

While the measure would keep police officers from searching vehicles due to the cannabis smell, it will not make any changes to the state’s impaired driving policies, which ban driving while under the influence of cannabis.

According to a press release from Illinois Democrats, SB 125 was filed in response to a Will County case where a police officer pulled over and arrested a defendant after the officer detected “a strong odor of burnt cannabis” from the defendant’s vehicle. However, the defendant argued that they had smoked marijuana in the car “a long time ago.”

The response bill states that the odor of marijuana cannot be a probable cause to search vehicles, car operators, and passengers or individuals aged 21 years and older. The measure also eliminates a state law provision that required marijuana in cars be put in odor-proof vessels.

Illinois recreational cannabis is relatively new, launched in 2020, but it has proven lucrative already. The adult-use market generated more than $1.5 billion in sales and $446.4 million in taxes for the state government in 2022.

Still, Illinois officials acknowledge that the recreational cannabis market has a long way to go. A 2020 report from state cannabis regulators revealed that Illinois’ adult-use industry has a shocking lack of racial and gender diversity. At the time of the report’s release, there were no social-equity applicants, people with disabilities, and people of color with major ownership of licensed cannabis businesses and only one licensed business with majority female ownership.

White people comprised 88% of majority owners, 71% of minority owners, 90% of the board of directors and 80% of c-suite executives, while Latino and Black people made up less than 10% of senior positions. This move to address another vestige of the prohibition era is likely to be applauded by cannabis industry actors and other companies such as Advanced Container Technologies Inc. (OTC: ACTX) because needless arrests will decrease.

NOTE TO INVESTORS: The latest news and updates relating to Advanced Container Technologies Inc. (OTC: ACTX) are available in the company’s newsroom at https://cnw.fm/ACTX

About CNW420

CNW420 spotlights the latest developments in the rapidly evolving cannabis industry through the release of two informative articles each business day. Our concise, informative content serves as a gateway for investors interested in the legalized cannabis sector and provides updates on how regulatory developments may impact financial markets. Articles are released each business day at 4:20 a.m. and 4:20 p.m. Eastern – our tribute to the time synonymous with cannabis culture. If marijuana and the burgeoning industry surrounding it are on your radar, CNW420 is for you! Check back daily to stay up-to-date on the latest milestones in the fast -changing world of cannabis.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CNW420.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW420? Ask our Editor

CannabisNewsWire420
Denver, Colorado
http://www.CNW420.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CNW420 is part of the InvestorBrandNetwork.

Lexaria Bioscience Corp. (NASDAQ: LEXX) Revolutionizing Drug Delivery Potential for Active Pharmaceutical Ingredients Using Patented DehydraTECH(TM) Technology

  • DehydraTECH(TM)-enabled drugs and product formats improve the speed of onset, increase bioavailability, increase brain absorption, enhance drug potency, reduce drug administration costs, and mask unwanted tastes, shown effective with a growing number of medical applications
  • Current DehydraTECH studies (animal and human) include hypertension, dementia, oral nicotine, epilepsy, and diabetes
  • Most recently, Lexaria’s DehydraTECH-CBD studies for hypertension have produced positive results, and the company is seeking IND status with the FDA

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug delivery platforms, has developed a disruptive drug delivery technology with multiple opportunities for success in cannabinoids, oral nicotine and other active pharmaceutical ingredients (“APIs”). Lexaria’s patented DehydraTECH(TM) technology is a formulation and dehydration processing procedure that changes how the body detects and absorbs drugs. The company currently has 28 granted patents, with many more pending patents in countries worldwide.

Lexaria specifically designed DehydraTECH for formulating and delivering topical or oral lipophilic (fat-soluble) drugs and APIs to increase effectiveness and improve how they enter the bloodstream. The major benefits of a DehydraTECH-enabled drug or consumer product include the following:

  • Faster delivery time – the effects of the product are felt by the subject in minutes
  • Increased bioavailability – the technology is more effective at delivering a drug or product into the bloodstream
  • Increased brain absorption –testing suggests significant improvement in the quantity of the drug or product delivered across the blood-brain barrier
  • Improved drug potency – more of the drug or product is made available in the body, requiring lower dosages for the desired outcome
  • Reduced drug administration costs – lower dosages mean lower overall drug costs
  • Improved taste – the technology eliminates the necessity for sweeteners to eliminate or reduce unwanted taste

One of Lexaria’s studies is cannabidiol (“CBD”) for hypertension, which has produced positive results for the company to seek Investigational New Drug (“IND”) status with the United States Food and Drug Administration (“FDA”). The company has completed a pre-IND meeting and intends to file for IND status in 2023. Lexaria’s first and subsequent DehydraTECH-CBD human studies have shown superior human blood absorption levels and demonstrated a potential novel mechanism of action in reducing blood pressure. More information on Lexaria’s current studies can be found on the company’s fact sheet (https://ir.lexariabioscience.com/presentations).

The global non-prescription CBD market was valued at $4.9 billion in 2021 and is expected to reach $47.22 billion in 2028, growing at a CAGR of 21.3% (https://cnw.fm/Iqpis). There has also been increased product acceptance and use due to FDA approval of one type of CBD. CBD is being studied in a variety of medical applications worldwide, including anxiety and depression treatment, stress reduction, diabetes prevention, pain relief, cancer symptom relief, and inflammation relief. Lexaria is currently exploring DehydraTECH-CBD-enabled formulations for hypertension, epilepsy, diabetes and dementia indications.

Since 2016, Lexaria’s DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption, reduce onset time from hours to just minutes, and mask unwanted tastes. The company intends to further evaluate the technology for other oral and topical use potential in cannabinoids, oral nicotine and other APIs.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

To receive instant SMS alerts, text CANNABIS to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.cannabisnewswire.com

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published: http://CNW.fm/Disclaimer

Do you have questions or are you interested in working with CNW? Ask our Editor

CannabisNewsWire (CNW)
Denver, Colorado
www.cannabisnewswire.com
303.498.7722 Office
Editor@CannabisNewsWire.com

CannabisNewsWire is part of the InvestorBrandNetwork.